Engbersen, M. P. http://orcid.org/0000-0002-4523-2345
Rijsemus, C. J. V.
Nederend, J.
Aalbers, A. G. J.
de Hingh, I. H. J. T.
Retel, V.
Lambregts, D. M. J.
Van der Hoeven, E. J. R. J.
Boerma, D.
Wiezer, M. J.
De Vries, M.
Madsen, E. V. E.
Brandt-Kerkhof, A. R. M.
Van Koeverden, S.
De Reuver, P. R.
Beets-Tan, R. G. H.
Kok, N. F. M.
Lahaye, M. J.
Funding for this research was provided by:
ZonMw (852002003)
Article History
Received: 14 September 2020
Accepted: 11 April 2021
First Online: 26 April 2021
Declarations
:
: Patients will need to provide written informed consent to participate with this study. The study has been approved by the Medical Ethics Committee of the Netherlands Cancer Institute (reference number: NL70045.031.19).
: Not applicable.
: The authors declare that they have no competing interests.